Drugs with this side effect as MedDRA Preferred Term
- 1,25(OH)2D3
- 2-hydroxysuccinaldehyde
- 5-ASA
- 5-aza-2'-deoxycytidine
- 5-azacytidine
- Hypertension: common, 1.14% - 8.57%
- A77 1726
- ACTH(1-39
- Hypertension: postmarketing, 11%
- Anidulafungin
- Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2
- BCNU
- BPTI
- Bivalirudin
- CAS 76420-72-9
- Hypertension: postmarketing
- CGP 19835A
- Hypertension: very common, 26%
- Cancidas
- Carfilzomib
- Hypertension: 0.38% - 14.3%
- Eptifibatide
- FK463
- FTY720
- Fe(III
- Hypertension: postmarketing, 0.4% - 23%
- Forteo
- Gd-DTPA
- Ge-132
- Glat copolymer
- Goserelin
- Hypertension: postmarketing, 1-10% - 12%
- Implanon
- Insulin
- Hypertension: 3.9% - 5.3%
- K779
- Hypertension: postmarketing
- L-Dmp
- L-threo-DOPS
- Hypertension: 1.53% - 7.02%
- LY146032
- Hypertension: postmarketing, common, 1.1% - 5.83%
- Lantus
- Hypertension: 18.9% - 19.6%
- Leuprorelin
- Hypertension: postmarketing, 5% - 8%
- Lovaza
- Lutalyse
- MDV3100
- Hypertension: 2.1% - 6.4%
- MK-462
- Meropenem anhydrous
- Metrodin
- MnDPDP
- Octreotide
- Hypertension
- Hypertension worsened
- Hypertensive
- Optison
- Hypertension: postmarketing, rare
- PCI-32765
- PGE1
- PGE2
- Photofrin
- Hypertension: postmarketing, 0% - 6%
- Photofrin II
- Protirelin
- Revasc
- S-benzoylmercaptoacetyltriglycine
- SOM230
- Hypertension: 9.76% - 10%
- Sativex
- Signifor
- Hypertension: 9.76% - 10%
- Stalevo 50
- TR-700
- Terlipressin
- Hypertension: postmarketing
- Triptorelin
- Hypertension: 0.8% - 14.2%
- Trisequens
- UDCA
- VACV
- Hypertension: postmarketing, 11% - 38%
- Zyprexa Relprevv
- abiraterone
- Hypertension: 0.3% - 3.9%
- acamprosate
- acetaminophen
- acyclovir
- Hypertension: postmarketing
- adenosine
- Hypertension: postmarketing
- alfentanil
- aliskiren
- Uncontrolled hypertension
- allopurinol
- almotriptan
- alosetron
- amantadine
- amifostine
- amisulpride
- amitriptyline
- amoxapine
- amphetamine
- amphotericin B
- Hypertension: 2.33% - 23.1%
- anagrelide
- anastrozole
- Hypertension: 4.94% - 13%
- anthracycline
- aprepitant
- Hypertension: 2.1% - 3.2%
- aripiprazole
- arsenic
- arsenic trioxide
- asenapine
- aspirin
- atazanavir
- avanafil
- axitinib
- azelastine
- Hypertension: postmarketing
- azithromycin
- baclofen
- Hypertension: uncommon, 0.2% - 2%
- bendamustine
- bepridil
- betamethasone dipropionate
- bexarotene
- Hypertension: uncommon, 10%
- bicalutamide
- bimatoprost
- Hypertension: postmarketing, 0.8% - 1.9%
- boceprevir
- bortezomib
- bretylium
- brimonidine
- brinzolamide
- bromocriptine
- Hypertension: postmarketing
- budesonide
- bupivacaine
- Hypertension: 0.982% - 1.77%
- buprenorphine
- bupropion
- Hypertension: postmarketing, 1% - 4.3%
- buspirone
- busulfan
- butorphanol
- cabazitaxel
- cabergoline
- cabozantinib
- caffeine
- candesartan
- Hypertension: postmarketing
- capecitabine
- capsaicin
- Hypertension: uncommon, 1% - 2%
- carbamazepine
- carbidopa
- carboplatin
- carboprost
- carnitine
- carvedilol
- Hypertension: 0.1% - 2.9%
- cefdinir
- Hypertension: postmarketing
- cefpodoxime
- ceftobiprole
- celecoxib
- Hypertension: 6.1% - 12.5%
- Hypertension worsened
- cetirizine
- cevimeline
- Hypertension
- Hypertension worsened
- chlorhexidine
- chlorpheniramine
- ciclesonide
- cidofovir
- cilazapril
- Hypertension: postmarketing, 1.2%
- cilostazol
- cinacalcet
- ciprofloxacin
- Hypertension: postmarketing
- cisatracurium
- citalopram
- Hypertension: infrequent, uncommon, frequent
- Hypertension worsened: rare, uncommon
- clindamycin
- clobetasone butyrate
- clofarabine
- clomiphene citrate
- Hypertension: postmarketing
- clomipramine
- clopidogrel
- clozapine
- colesevelam
- Hypertension: 2.56% - 2.83%
- conivaptan
- copolymer 1
- cortisol
- cortisone
- cosyntropin
- cyclizine
- cyclobenzaprine
- Hypertension: postmarketing
- cyclophosphamide
- Hypertension: postmarketing
- cysteamine
- cytarabine
- Hypertension: 3.57% - 15.2%
- dabigatran etexilate
- dabrafenib
- Hypertension
- Refractory hypertension
- dalteparin
- danazol
- dantrolene
- dapagliflozin
- darifenacin
- darunavir
- Hypertension: uncommon, 0.2%
- dasatinib
- Hypertension: postmarketing, common, 0% - 2%
- deferiprone
- Hypertension: postmarketing
- degarelix
- delamanid
- delavirdine
- demethyl
- deprenyl
- Hypertension: frequent, 3%
- desflurane
- desipramine
- desmopressin
- desogestrel
- desvenlafaxine
- dexamethasone
- Hypertension: 6.4% - 12.7%
- dexamethasone sodium phosphate
- dexmedetomidine
- Hypertension: postmarketing, very common, 4% - 30%
- Hypertension worsened
- diatrizoate
- diazoxide
- diclofenac
- Hypertension: very rare, postmarketing, 0% - 3%
- dicyclomine
- Hypertension: postmarketing
- dihydroergotamine
- Hypertension: postmarketing
- dipivefrin
- dipyridamole
- docetaxel
- Hypertension: postmarketing, common, 1.6% - 2%
- dofetilide
- dolasetron
- Hypertension: 2.19% - 2.88%
- donepezil
- Hypertension: frequent, 3%
- dopamine
- dorzolamide
- dothiepin
- doxazosin
- Hypertension worsened
- Hypertensive: postmarketing, 27%
- doxepin
- doxercalciferol
- doxorubicin
- doxycycline
- doxycycline hyclate
- droperidol
- duloxetine
- efavirenz
- eletriptan
- entacapone
- ephedrine
- epinephrine
- ergonovine
- ergotamine
- ertapenem
- eslicarbazepine
- eslicarbazepine acetate
- esomeprazole magnesium
- estradiol
- estramustine phosphate
- etodolac
- etomidate
- etoposide
- etoposide phosphate
- etoricoxib
- etravirine
- everolimus
- Hypertension: common, very common, 0% - 47.4%
- exemestane
- Hypertension: 1.7% - 15.1%
- exenatide
- Hypertension: 1.21% - 3.14%
- ezetimibe
- febuxostat
- felbamate
- fenofibrate
- fenofibric acid
- fentanyl
- Hypertension: very rare, postmarketing, 0% - 1%
- ferumoxytol
- Hypertension: postmarketing, 1%
- flecainide
- fluconazole
- fludrocortisone
- fludrocortisone acetate
- flumazenil
- flunisolide
- fluorescein
- Hypertension: very rare, postmarketing
- fluoxetine
- fluphenazine
- fluphenazine decanoate
- flurbiprofen
- flutamide
- fluticasone
- fluticasone propionate
- fluvastatin
- fluvoxamine
- Hypertension: infrequent, frequent, 1% - 2%
- formoterol
- Hypertension: postmarketing
- fosaprepitant dimeglumine
- Hypertension: 2.1% - 3.2%
- foscarnet
- fosinopril
- fosphenytoin
- gabapentin
- Hypertension: infrequent, frequent
- gadobenate dimeglumine
- Hypertension: postmarketing
- gadofosveset
- gadolinium
- gadopentetate
- gadoteridol
- Hypertension: postmarketing
- gadoversetamide
- galantamine
- Hypertension: postmarketing, frequent, 4%
- ganciclovir
- gatifloxacin
- gemcitabine
- gentamicin
- gliclazide
- Hypertension: 3.2% - 3.7%
- glimepiride
- glipizide
- glucagon
- glucagon hydrochloride
- glucose
- glycopyrrolate
- granisetron
- Hypertension: infrequent, common, 1% - 2.6%
- guanfacine
- halcinonide
- haloperidol
- histamine
- hydromorphone
- hydroxybutyrate
- Hypertension: postmarketing
- ibandronate
- Hypertension: 5.3% - 7.3%
- ibuprofen
- ibutilide
- icodextrin
- ifosfamide
- Hypertension: postmarketing, 1%
- imatinib
- Hypertension: infrequent, uncommon
- imipramine
- imiquimod
- indomethacin
- insulin detemir
- iodixanol
- iohexol
- iopamidol
- iopromide
- ioversol
- ioxilan
- ipratropium bromide
- Hypertension: 0.9% - 1.9%
- Hypertension worsened: 0.9% - 1.9%
- irbesartan
- Hypertension: postmarketing
- irinotecan
- iron sucrose
- isomannide
- isopropyl unoprostone
- isoproterenol
- isosorbide-5-mononitrate
- itraconazole
- ketoprofen
- ketorolac
- ketorolac tromethamine
- Hypertension: postmarketing
- ketotifen
- labetalol
- lamotrigine
- Hypertension: rare, infrequent
- lanreotide
- Hypertension
- Hypertension worsened
- lansoprazole
- leflunomide
- lenalidomide
- Hypertension: postmarketing, uncommon, 6.08% - 7.93%
- letrozole
- Hypertension: uncommon, 4% - 8%
- leuprorelin acetate
- levodopa/carbidopa
- levonorgestrel
- lidocaine
- linezolid
- lisdexamfetamine dimesylate
- lomefloxacin
- loratadine
- lorazepam
- lorcaserin
- loxapine
- lurasidone
- Hypertension: infrequent, frequent
- mannitol
- maprotiline
- mefenamic acid
- mefloquine
- Hypertension: postmarketing
- megestrol
- megestrol acetate
- melatonin
- meloxicam
- memantine
- Hypertension: 3.98% - 4%
- Hypertension worsened
- meperidine
- mepivacaine
- meropenem
- mesna
- Hypertension: postmarketing
- metaproterenol
- metformin
- methylene blue
- methylergometrine
- methylphenidate
- methylprednisolone
- methylprednisolone sodium succinate
- metipranolol
- metoclopramide
- Hypertension: postmarketing
- metolazone
- metoprolol
- metronidazole
- Hypertension: 0.529% - 1.08%
- metyrapone
- mexiletine
- mianserin
- midodrine
- Hypertension: uncommon, common, 0% - 7.3%
- mifepristone
- milnacipran
- minocycline
- Hypertension: 0.8% - 2.8%
- mipomersen
- mirabegron
- Hypertension: 0.5% - 11.3%
- mirtazapine
- Hypertension: postmarketing, frequent
- misoprostol
- Hypertension: postmarketing
- mitomycin C
- mitotane
- mitoxantrone
- moclobemide
- modafinil
- Hypertension: postmarketing
- morphine
- moxifloxacin
- mycophenolate mofetil
- Hypertension: 2.8% - 77.5%
- mycophenolic acid
- Hypertension: 18% - 77.5%
- Hypertension worsened
- nabilone
- nabumetone
- Hypertension: postmarketing, 1.7%
- nadolol
- nalbuphine
- nalmefene
- naloxone
- naltrexone
- nandrolone decanoate
- naphazoline
- naproxen
- Hypertension: postmarketing
- nefazodone
- nepafenac
- nesiritide
- nicardipine
- nicorandil
- nicotine
- nilotinib
- nilutamide
- nimodipine
- nitazoxanide
- norepinephrine
- nortriptyline
- ofatumumab
- ofloxacin
- Hypertension
- Hypertension worsened
- olanzapine
- olsalazine
- omeprazole
- oxaliplatin
- Hypertension: rare, common
- oxaprozin
- oxcarbazepine
- oxybutynin
- oxymorphone
- oxytocin injection
- paclitaxel
- Hypertension: uncommon, 1%
- paliperidone
- palonosetron
- pamidronate
- Hypertension: common, 0% - 6%
- pantoprazole
- parecoxib
- paricalcitol
- paroxetine
- Hypertension: postmarketing, infrequent, common, frequent, 2%
- Hypertension worsened: postmarketing
- pazopanib
- pegaptanib
- pegaptanib sodium
- pemetrexed
- pentamidine
- pentazocine
- pentostatin
- pentoxifylline
- pergolide
- Hypertension: frequent, 1.6%
- perindopril erbumine
- Hypertensive: postmarketing
- perindoprilat
- Hypertensive: postmarketing
- perphenazine
- phentermine
- phentolamine
- phenylephrine
- phenytoin
- pilocarpine
- pimozide
- pioglitazone
- piroxicam
- ponatinib
- posaconazole
- pramipexole
- prasugrel
- Hypertension: 7.1% - 7.5%
- pravastatin
- prednisolone
- prednisolone acetate
- prednisolone phosphate
- prednisone
- pregabalin
- Hypertension: frequent, 2.2%
- prilocaine
- procaine
- procarbazine
- progesterone
- Hypertension: postmarketing
- propafenone
- propofol
- protriptyline
- quetiapine
- rabeprazole
- raltegravir
- rapamycin
- Hypertension: very common, 23% - 49%
- rasagiline
- rasburicase
- reboxetine
- Hypertension: postmarketing, 1.18%
- regadenoson
- Hypertension: postmarketing, uncommon
- regorafenib
- remifentanil
- repaglinide
- rescinnamine
- retinoic acid
- ribavirin
- rifapentine
- riluzole
- Hypertension: 3.3% - 6.8%
- rimantadine
- risedronate
- Hypertension: 4.2% - 10.6%
- risperidone
- Hypertension: postmarketing, infrequent, 1% - 3%
- ritonavir
- rivastigmine
- Hypertension: very rare, postmarketing, common, 1% - 3%
- rizatriptan
- rocuronium
- rofecoxib
- Hypertension: 1.6% - 8.2%
- ropinirole
- Hypertension: postmarketing, frequent, 3% - 5%
- Hypertension worsened
- ropivacaine
- Hypertension: 0.5% - 8.3%
- rosiglitazone
- Hypertension: 4.4% - 6.1%
- rotigotine
- salbutamol
- Hypertension: postmarketing, 1% - 3.1%
- salmeterol
- salmon calcitonin acetate
- Hypertension: postmarketing, uncommon
- samarium
- saquinavir
- sertraline
- Hypertension: postmarketing, infrequent, uncommon
- Hypertension worsened: rare
- sevelamer hydrochloride
- Hypertension: 5.9% - 10.1%
- sevoflurane
- sibutramine
- sildenafil
- Hypertension: postmarketing, rare
- sitagliptin
- sodium acetate
- sodium ferric gluconate
- sodium iothalamate
- solifenacin
- Hypertension: 0.5% - 1.4%
- sorafenib
- Hypertension: postmarketing, 1% - 17%
- sotalol
- sparfloxacin
- succinylcholine
- sufentanil
- sugammadex
- sulindac
- sumatriptan
- Hypertension: infrequent, 1%
- Hypertensive episode
- sunitinib
- tacrolimus
- Hypertension: very common, 0% - 91.1%
- tadalafil
- Hypertension: postmarketing, 1% - 3%
- tamoxifen
- Hypertension: 7-11% - 13%
- tamsulosin
- telavancin
- telmisartan
- Hypertension: 1%
- Hypertension worsened: postmarketing
- temozolomide
- temsirolimus
- teniposide
- tesamorelin
- Hypertension: 1.3% - 1.6%
- testosterone
- Hypertension: postmarketing, uncommon, 0% - 3%
- Hypertension worsened: 0.2% - 1.3%
- testosterone enanthate
- Hypertension: postmarketing
- testosterone propionate
- testosterone undecanoate
- tetrofosmin
- thalidomide
- thiotepa
- tiagabine
- ticagrelor
- tigecycline
- Hypertension: 4.9% - 5.6%
- timolol
- Hypertension: postmarketing
- tiotropium
- tirofiban
- tizanidine
- tofacitinib
- Hypertension: 1.6% - 2.3%
- tolcapone
- topiramate
- tramadol
- Hypertension: postmarketing, uncommon, 2.3% - 2.33%
- Hypertension worsened: postmarketing, uncommon, 1.86% - 1.9%
- trametinib
- Hypertension: 3% - 15%
- Refractory hypertension
- tranylcypromine
- Hypertension paroxysmal
- Hypertensive
- travoprost
- Hypertension: rare, uncommon
- trazodone
- Hypertension: 1.3% - 2.1%
- triamcinolone
- triamcinolone acetonide
- triazolam
- triiodothyronine
- trimipramine
- tropisetron
- Hypertension: 0.568% - 5.69%
- trovafloxacin
- unoprostone
- v 1784
- Hypertension: postmarketing, very common, 0% - 53%
- valdecoxib
- Hypertension
- Hypertension worsened
- valganciclovir
- valproate
- vandetanib
- varenicline
- venlafaxine
- Hypertension: common, 1.1% - 5%
- verapamil
- Hypertension: postmarketing, 1.7%
- verteporfin
- vinblastine
- vincristine
- vinflunine
- vinorelbine
- Hypertension: postmarketing
- vitamin D2
- voriconazole
- zalcitabine
- zaleplon
- ziprasidone
- Hypertension: frequent, 0% - 3%
- zoledronic acid
- Hypertension: uncommon, common, 5.1% - 12.7%
- zolmitriptan
- zolpidem
- Hypertension: infrequent
- Hypertension worsened: rare
- zonisamide
- zopiclone
- zuclopenthixol
|
Drugs with this indication
|